A federal judge ruled earlier this week that stem cell therapies are procedures, not drugs, and that the FDA has no jurisdiction over them, blocking the agency’s attempt to regulate the California Stem Cell Treatment Center’s (CSCTC) products.
Source: Drug Industry Daily